ICARUS
Identification of Circadian Rhythm Deregulation in Patients With Cryopyrin-associated Periodic Syndrome (CAPS)
Sponsor study identifier
Secondary identifiers
OTHER · ID-RCB
interventional
30
1 country
6
Study Start
February 25, 2026
Actual (reported)Primary Completion
February 25, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 25, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Circadian rhythms are characterized by the physiology's adaptation to the alternation of day and night, enabling to adapt to the environment. These rhythms are generated by a molecular clock within each cell. At the molecular level, the circadian clock is based on a complex system of cell-autonomous transcription loops. These exert positive and negative feedback on themselves, generating cyclic transcriptional activity.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 25, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 7, 2024
Actual (reported)August 9, 2024
Actual (reported)February 25, 2026
Actual (reported)February 25, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
February 25, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Description of circadian rhythm deregulation in patients with cryopyrinopathy (CAPS) whose diagnosis was confirmed by genetic analysis of NLRP3,
Concentration of the peak secretion of melatonin in both arms
6 months after inclusion
Description of circadian rhythm deregulation in patients with cryopyrinopathy (CAPS) whose diagnosis was confirmed by genetic analysis of NLRP3,
Concentration of the peak secretion of melatonin in both arms
12 months after inclusion
Description of circadian rhythm deregulation in patients with cryopyrinopathy (CAPS) whose diagnosis was confirmed by genetic analysis of NLRP3,
time of the peak secretion of melatonin in both arms
6 months after inclusion
Confirmed by genetic analysis of NLRP3
Healthy participant (absence of CAPS, verified by NLRP3 gene analysis) living in the same household as a CAPS participant included in the protocol
Blood test for genetic analysis of NLRP3
Wear a Withings Pulse HR (heart rate) actigraphic watch 24 hours a day for 1 month to define circadian rhythm
Hôpital Femme-Mère-Enfant (HCL)
Bron, 69677, France
Hôpital Claude Huriez (CHU de Lille)
Lille, 59037, France
First Submitted
May 7, 2024
First Posted
August 9, 2024
Study Start
February 25, 2026
Actual (reported)Primary Completion
February 25, 2029
Description of circadian rhythm deregulation in patients with cryopyrinopathy (CAPS) whose diagnosis was confirmed by genetic analysis of NLRP3,
time of the peak secretion of melatonin in both arms
12 months after inclusion
Difference in circadian clock biomarkers between patients and control participants for Circadian Rhythm Characteristics.
6 th month
Difference in circadian clock biomarkers between patients and control participants for Circadian Rhythm Characteristics.
6 th month
Difference in circadian clock biomarkers between patients and control participants for Circadian Rhythm Characteristics.
6 th month
Chronotype determination
6 th month
sleep duration
6 th month
Saliva sampling for salivary melatonin determination
Questionnaire to determine chronotype
Disease activity score using AIDAI score (only for patients in the CAPS group) AIDAI : AUTO-INFLAMMATORY DISEASE ACTIVITY INDEX
1. Inflammatory cytokines measurement : IL1-beta (Interleukin-1) and IL-18. 2. Molecular characterization of circadian clock signaling pathways
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Hôpital de la Croix-Rousse (HCL)
Lyon, 69004, France
Hôpital Edouard Herriot (HCL)
Lyon, 69437, France
Hôpital Tenon (AP-HP)
Paris, 75020, France
Hôpital Kremlin-Bicêtre (AP-HP)
Paris, 94270, France
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 25, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
February 27, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: